Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Germline mosaicism in X-linked periventricular nodular heterotopia

  • Monique M LaPointe1,
  • Elizabeth L Spriggs1, 2 and
  • Aizeddin A Mhanni1, 2, 3Email author
BMC Neurology201414:125

DOI: 10.1186/1471-2377-14-125

Received: 6 March 2014

Accepted: 28 May 2014

Published: 7 June 2014

Abstract

Background

X-linked periventricular nodular heterotopia is a disorder of neuronal migration resulting from mutations in the filamin A gene. This is an X-linked dominant condition where most affected patients are female and present with seizures. Extra–cerebral features such as cardiac abnormalities and thrombocytopenia have also been documented. Loss of function mutations in filamin A are predicted to result in prenatal lethality in males. Somatic mosaicism and mutations that lead to partial loss of function of the protein are hypothesized to explain viability of males reported in the literature. We report the first case of germline mosaicism involving a loss of function mutation in filamin A in a family where brain MRI, clinical exam, and mutation analysis is normal in both biological parents.

Case presentation

The index patient, a 39 year old female with normal development, had her first seizure at 24 years with no evidence of any precipitating factors. Brain MRI shows bilateral periventricular nodular heterotopia. She has thrombocytopenia and an echocardiogram at age 32 years revealed a mildly dilated aortic root and ascending aorta with mild aortic regurgitation. The second patient, the 36 year old younger sister of the index case, is currently healthy with no evidence of seizures or cardiac abnormalities. Her brain MRI is consistent with bilateral periventricular nodular heterotopia. The mother is healthy at 57 years of age with a normal brain MRI. The father is healthy at 59 years of age with a normal brain MRI. DNA sequencing of lymphocyte extracted DNA from the two sisters shows a c.2002C > T transition in exon 13 of filamin A resulting in a p.Gln668Ter mutation. This nonsense mutation was not detected in peripheral blood lymphocytes from the unaffected parents.

Conclusion

This report provides evidence for germline mosaicism in filamin A-associated periventricular nodular heterotopia. This case must now be considered when providing genetic counseling to families where a proband presents as an isolated case and parental investigations are unremarkable.

Keywords

X-linked periventricular nodular heterotopia Germline mosaicism Genetic counseling

Background

Periventricular nodular heterotopia (PNH) is a disorder of cortical development [1]. PNH is a term used to describe the collections of neurons lining the lateral ventricles that have failed to migrate normally to form the cerebral cortex [1]. It is a clinically and genetically heterogeneous group of disorders [2]. Mutations in the filamin A gene (FLNA) result in an X-linked dominant form of this disorder [3]. Mutations in FLNA leading to protein truncation are the predominant cause of the PNH phenotype [2, 4]. Most affected females present with seizures and normal to mildly impaired cognitive function [2, 5]. FLNA-associated PNH may also be associated with other cerebral malformations as well as extra-cerebral features [6]. The condition typically results in prenatal lethality or a more severe phenotype in males although paternal transmission has been documented in the literature [2, 79].

Mutations in FLNA are associated with a wide spectrum of disorders including the otopalatodigital syndrome (OPD) spectrum disorders [10]. The phenotypes of these disorders are clinically distinct from FLNA-associated PNH and result from mutations that conserve the reading frame [10]. FLNA post-zygotic mutations and germline mosaicism have been reported in the OPD spectrum disorders [10].

We present the first documented evidence for germline mosaicism in a family with two sisters with FLNA-associated PNH due to a loss of function mutation in FLNA and clinically unaffected parents.

Case presentation

The index patient, a 38 year old female, was born after an uneventful pregnancy and delivery. Shortly after delivery she was found to have an ectopic 3rd kidney and a patent ductus arteriosus which required surgical closure at 18 months of age. Her development was normal with no history of seizures, meningitis, encephalitis or major head trauma. She was noted to have thrombocytopenia at age 23 years after complaints of unexplained weight loss. Bone marrow aspiration did not reveal any abnormalities. She continues to have easy bruising and prolonged bleeding time. She had her first seizure at 24 years with no evidence of any precipitating factors. Her neurologic examination was normal. Brain magnetic resonance imaging (MRI) revealed bilateral multiple and diffuse PNH (Figure 1). She has episodic headache with photophobia and phonophobia. An echocardiography at age 32 years revealed a mildly dilated aortic root and ascending aorta with mild aortic regurgitation.The second patient, a younger sister of the index case, is now 36 years of age. Her medical history is relevant for migraine headaches with visual aura. Her neurologic examination was normal and her EEG did not show any interictal abnormalities. An MRI of the brain shows heterotopic gray matter of both hemispheres (Figure 2). Her echocardiogram was normal.
https://static-content.springer.com/image/art%3A10.1186%2F1471-2377-14-125/MediaObjects/12883_2014_Article_1036_Fig1_HTML.jpg
Figure 1

Brain MRI of the index patient showing PNH.

https://static-content.springer.com/image/art%3A10.1186%2F1471-2377-14-125/MediaObjects/12883_2014_Article_1036_Fig2_HTML.jpg
Figure 2

Brain MRI of the sister showing PNH.

The parents are a healthy nonconsanguineous couple. The mother is now 56 years. She is of English, Irish, and Belgian ethnic background. Her past medical history is unremarkable. Her brain MRI does not show evidence of PNH. The father is now 58 years. He is of Ukrainian and Polish ethnic background. His past medical history is unremarkable. His brain MRI does not show evidence of PNH.

Mutation analysis

DNA sequencing revealed both sisters to be heterozygous for a c.2002C > T transition in exon 13 of the FLNA gene resulting in a p.Gln668Ter mutation. This nonsense mutation has previously been reported as a FLNA disease-causing mutation in a patient with PNH [5]. Analysis of lymphocyte extracted DNA from the mother and father did not reveal the FLNA exon 13 mutation. Parental relationships were verified molecularly using the Identifier kit (Applied Biosystems).

Conclusions

We describe two sisters with PNH due to a FLNA nonsense mutation. This mutation was not identified in extracted DNA from the lymphocytes of the clinically unaffected parents. Brain MRI in both parents does not show PNH. The most likely explanation for this finding is germline mosaicism.

It is possible that either parent is also somatic mosaic for this FLNA mutation as Sanger sequencing may not detect low levels of mosaicism [11]. Furthermore, mutation detection in the parents was limited to peripheral lymphocytes. Somatic mosaicism has been reported in males and females with FLNA-PNH. All individuals in these studies had PNH identified on brain MRI although clinically they may have been asymptomatic [8, 9, 12]. Somatic and germline mosaicism was reported in a male with a deleterious splice site mutation in FLNA [9]. In contrast to our family however, this individual had PNH identified on brain MRI and had other clinical features consistent with the FLNA-PNH phenotype [9].

In view of this case report, germline mosaicism should be considered in counseling families where there is an isolated case of FLNA-associated PNH and neither parent has any clinical, radiographic or molecular evidence of FLNA-associated PNH. Despite the apparent low risk of recurrence in such cases, prenatal testing should be considered for subsequent pregnancies.

Consent

Written informed consent was obtained from the patient for publication of the case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.

Abbreviations

PNH: 

Periventricular nodular heterotopia

FLNA

Filamin A gene.

Declarations

Authors’ Affiliations

(1)
Department of Biochemistry and Medical Genetics Faculty of Medicine, University of Manitoba
(2)
Department of Pediatrics and Child Health, University of Manitoba
(3)
Genetics and Metabolism Program

References

  1. Ekşioğlu YZ, Schetter IE, Cardenas P, Knoll J, DiMario F, Ramsby G, Berg M, Kamuro K, Berkovic SF, Duyk GM, Parisi J, Huttenlocher PR, Walsh CA: Periventricular heterotopia: an X-linked dominant epilepsy locus causing aberrant cerebral cortical development. Neuron. 1996, 16: 77-87. 10.1016/S0896-6273(00)80025-2.View ArticlePubMedGoogle Scholar
  2. Guerrini R, Parrini E: Neuronal migration disorders. Neurobiol Dis. 2010, 38: 154-166. 10.1016/j.nbd.2009.02.008.View ArticlePubMedGoogle Scholar
  3. Online mendelian inheritance in man. http://www.omim.org/entry/300049?search=300049&highlight=300049,
  4. Fox JW, Lamperti ED, Ekşioğlu YZ, Hong SE, Feng Y, Graham DA, Scheffer IE, Dobyns WB, Hirsch BA, Radtke RA, Berkovic SF, Huttenlocher PR, Walsh CA: Mutations in filamin 1 prevent migration of cerebral cortical neurons in human periventricular heterotopias. Neuron. 1998, 21: 1315-1325. 10.1016/S0896-6273(00)80651-0.View ArticlePubMedGoogle Scholar
  5. Parrini E, Ramazzotti A, Dobyns WB, Mei D, Moro F, Veggiotti P, Marini C, Brilstra EH, Bernardina D, Goodwin L, Bodell A, Jones MC, Nangeroni M, Palmeri S, Said E, Sander JW, Striano P, Takahashi Y, Maldergem LV, Leonardi G, Wright M, Walsh CA, Guerrini R: Periventricular heterotopia: phenotypic heterogeneity and correlation with filamin A mutations. Brain. 2006, 129: 1892-1906. 10.1093/brain/awl125.View ArticlePubMedGoogle Scholar
  6. Fergelot P, Coupry I, Rooryck C, Deforges J, Maurat E, Solé G, Boute O, Dieux-Coeslier A, David A, Marchal C, Thambo JB, Lacombe D, Arveiler B, Goizet C: Atypical male and female presentations of FLNA-related periventricular nodular heterotopia. Eur J Med Genet. 2012, 55: 313-318. 10.1016/j.ejmg.2012.01.018.View ArticlePubMedGoogle Scholar
  7. Dobyns WB, Andermann E, Andermann F, Czapansky-Beilman D, Dubeau F, Dulac O, Guerrini R, Hirsch B, Ledbetter DH, Lee NS, Motte J, Pinard JM, Radtke RA, Ross ME, Tampieri D, Walsh CA, Truwit CI: X-linked malformations of neuronal migration. Neurology. 1996, 47: 331-339. 10.1212/WNL.47.2.331.View ArticlePubMedGoogle Scholar
  8. Guerrini R, Mei D, Sisodiya S, Sicca F, Harding B, Takahashi Y, Dorn T, Yoshida A, Campistol J, Krämer G, Moro F, Dobyns WB, Parrini E: Germline and mosaic mutations of FLN1 in men with periventricular heterotopia. Neurology. 2004, 63: 51-565. 10.1212/01.WNL.0000132818.84827.4D.View ArticlePubMedGoogle Scholar
  9. Kasper BS, Kurzbuch K, Chang BS, Pauli E, Hamer HM, Winkler J, Hehr U: Paternal inheritance of classic X-linked bilateral periventricular nodular heterotopia. Am J Med Genet Part A. 2013, 161A: 1323-1328.View ArticlePubMedGoogle Scholar
  10. Robertson S, Thompson S, Morgan T, Holder-Espinasse M, Martinot-Duquenoy V, Wilkie AOM, Manouvrier-Hanu S: Postzygotic mutation and germline mosaicism in the otopalatodigital syndrome spectrum disorders. Eur J Med Genet. 2006, 14: 549-554.Google Scholar
  11. Rohlin A, Wernersson J, Engwall Y, Wiklund L, Björk J, Nording M: Parallel sequencing used in detection of mosaic mutations: comparison with four diagnostic DNA screening techniques. Hum Mutat. 2009, 30: 1012-1020. 10.1002/humu.20980.View ArticlePubMedGoogle Scholar
  12. Parrini E, Mei D, Wright M, Dorn T, Guerrini R: Mosaic mutations of the FLN1gene cause a mild phenotype in patients with periventricular heterotopia. Neurogenetics. 2004, 5: 191-196. 10.1007/s10048-004-0187-y.View ArticlePubMedGoogle Scholar
  13. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2377/14/125/prepub

Copyright

© LaPointe et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement